MacroGenics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +113.4% | -14.2% | +79.6% | -61.3% | +3.2% | +57.6% | -22.6% | +100.9% | -62.4% | +159.4% | +0.8% | |
| – | +16.6% | +24.2% | +20.6% | +29.6% | +2.3% | -1.1% | -98.6% | +178.5% | +11.3% | +49.6% | +251.1% | |
| – | +113.4% | -14.2% | +79.6% | -61.3% | +3.2% | +57.6% | -25.3% | +98.0% | -66.1% | +177.8% | -21.8% | |
| – | +40.0% | +24.2% | +20.6% | +29.6% | +2.3% | -1.1% | +11.1% | -3.5% | -19.5% | +6.4% | -21.0% | |
| – | +42.9% | +31.0% | +9.5% | +24.0% | +13.7% | -7.2% | +47.4% | -6.5% | -11.5% | +36.1% | -44.9% | |
| – | +41.4% | +21.1% | +21.2% | +30.2% | +3.4% | -4.3% | +20.5% | -3.6% | -18.3% | +13.5% | -27.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -61.3% | +443.7% | -22.0% | +663.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -212.0% | – | – | +3,503.5% | -90.0% | -171.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -2,944.2% | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.